Tejnaksh Healthcare Ltd.
Snapshot View

128.00 +6.95 ▲5.7%

31 January 2023, 11:44:00 AM
Volume: 6,537

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.tejnaksh.com
Market Cap 125.94 Cr.
Enterprise Value(EV) 125.92 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 2.58 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 48.03 Trailing Twelve Months Ending 2022-09
Industry PE 46.72 Trailing Twelve Months Ending 2022-09
Book Value / Share 21.21 Trailing Twelve Months Ending 2022-09
Price to Book Value 5.85 Calculated using Price: 124.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.02 Cr. 10,156,800 Shares
FaceValue 10
Company Profile
The company is an integrated healthcare delivery service provider, committed to delivering quality healthcare services to its patients in modern facilities. Its operations are divided across four key vertical streams in healthcare delivery, namely - “Pediatric Urology”, “Adult Urology (Male, Female)”, “Andrology and Sexual Dysfunction” and “Nephrology, Dialysis and Renal Transplant”. It offers a gamut of more than 65 healthcare services under these streams. A base of over 65 employees and consultants supports its healthcare facility network. The company's healthcare facilities use advanced technology and its doctors, nurses and other healthcare professionals follow treatment protocols that match international standards. A majority of its healthcare facilities provide secondary, tertiary and quaternary healthcare services to patients. Some of its healthcare facilities provide super speciality quaternary healthcare to patients in key specialty areas such as Pediatric Urology and Adult Urology (Male, Female).

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+5.74%
1 Week
-6.74%
1 Month
+17.49%
3 Month
+7.83%
6 Month
-10.89%
1 Year
-13.16%
2 Year
+142.65%
5 Year
+47.19%
10 Year
7 years 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 21.17 26.68 34.98 26.93 15.10 12.71 15.05
Return on Capital Employed (%) 34.00 29.35 32.66 27.59 17.78 14.20 17.20
Return on Assets (%) 19.32 16.96 17.97 14.93 9.10 8.36 10.38

Balance Sheet View Details >>

Particulars 8 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 6 8 10 13 15 17 20 21
Non Curr. Liab. 0 7 6 6 7 5 7 7
Curr. Liab. 0 1 3 2 2 2 2 2
Minority Int. 0 0 0 0 0 1 1
Equity & Liab. 7 16 20 22 25 25 30 31
Non Curr. Assets 6 14 17 18 18 21 25 25
Curr. Assets 1 2 3 5 7 3 5 6
Misc. Exp. not W/O
Total Assets 7 16 20 22 25 25 30 31

Profit Loss View Details >>

Particulars 8 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 5 7 14 20 17 12 13 12
Other Income 0 0 0 2 0 0 0 0
Total Income 5 7 15 21 17 12 13 13
Total Expenditure -2 -4 -9 -16 -13 -8 -8 -8
PBIDT 2 3 6 6 4 4 5 5
Interest 0 -1 -1 -1 -1 0 -1
Depreciation 0 0 0 -1 -1 -1 -1 -1
Taxation -1 -1 -1 -1 -1 -1 -1 -1
Exceptional Items
PAT 1 2 3 3 2 2 3 3
Minority Interest 0 0 0 0 0 0
Share Associate 0
Other Related Items
Consolidated Net Profit 1 2 3 3 2 2 3 3
Adjusted EPS 1 2 3 3 2 2 3 3

Cash Flow View Details >>

Particulars 7 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 4 2 4 3 1 1 9
Cash Fr. Inv. -3 -8 -3 -2 -1 2 -11
Cash Fr. Finan. 0 6 -1 -2 0 -3 2
Net Change 0 1 1 -1 0 0 0
Cash & Cash Eqvt 0 1 2 1 1 1 1

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 73.84 73.84 73.84 73.84 73.83 73.83 73.83 73.83 73.83
Public 26.16 26.16 26.16 26.16 26.17 26.17 26.17 26.17 26.17
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 30 Jan 2023
Board Meeting Intimation for Agenda Mentioned In Notice Enclosed Herewith.
Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2023 inter alia to consider and approve a. Un-audited financial result (Standalone and Consolidated) for quarter ended on December 31 2022;b. Sub-division of (Change in face value) of equity share of the Company; c. The Appointment of Mr. Nandish Dave Company Secretary as a Secretarial Auditor of the Company for FY 2022-23;d. Any other matter with the permission of the Chair.
Mon, 23 Jan 2023
Announcement Under Regulation 30
Announcement under Regulation 30 and Show Telecasted on Sony Liv -Shark Tank Season-2 of a Product Name P-Flow.
Sun, 15 Jan 2023
Announcement Under Regulation 30 W.R.T. Investor Meet At Shark Tank (Popular TV Show)
With reference to the subject cited above; we are pleased to inform you that Our Managing Director Dr. Ashish Rawandale and Director Dr. Preeti Rawandale presented our product Pflow in the tank. Thiswas done before the renowned Investors at Shark Tank which is popular Sony TV show.They showcased our product named P-FLOW which helps diagnose prostate and urine infection athome.This is to inform you that the show maybe telecasted on Sony Liv Entertainment Channel.

Technical Scans View Details >>

Mon, 30 Jan 2023
Opening at High Opening at High
High Increase in 1 Month High Increase in 1 Month
High Increase in 2 Years High Increase in 2 Years
Closing Near 100 SMA Closing Near 100 SMA
Close Crossing 100 SMA From Above Close Crossing 100 SMA From Above

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 252,338.06 1,039.45 -1.2%
Divi's Laboratories Ltd. 89,367.34 3,343.95 -0.7%
Cipla Ltd. 83,741.18 1,027.05 -0.7%
Dr. Reddy's Laboratories Ltd. 72,084.75 4,326.05 -0.1%
Apollo Hospitals Enterprise Ltd. 61,094.10 4,257.00 +0.5%
Torrent Pharmaceuticals Ltd. 52,291.51 1,518.10 -1.9%
Abbott India Ltd. 44,555.01 21,081.50 +0.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 61.43 1,039.45 -1.2%
Divi's Laboratories Ltd. Consolidated 2022-09 29.89 3,343.95 -0.7%
Cipla Ltd. Consolidated 2022-12 31.74 1,027.05 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.79 4,326.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.76 4,257.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.93 1,518.10 -1.9%
Abbott India Ltd. Standalone 2022-09 50.53 21,081.50 +0.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.75 1,039.45 -1.2%
Divi's Laboratories Ltd. Consolidated 2022-09 7.37 3,343.95 -0.7%
Cipla Ltd. Consolidated 2022-12 3.69 1,027.05 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.28 4,326.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.21 4,257.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,518.10 -1.9%
Abbott India Ltd. Standalone 2022-09 16.41 21,081.50 +0.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,039.45 -1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,343.95 -0.7%
Cipla Ltd. Consolidated 2022-03 0.04 1,027.05 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,326.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,257.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,518.10 -1.9%
Abbott India Ltd. Standalone 2022-03 0.00 21,081.50 +0.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,039.45 -1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,343.95 -0.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.05 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,326.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,257.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.10 -1.9%
Abbott India Ltd. Standalone 2022-03 29.95 21,081.50 +0.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,039.45 -1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,343.95 -0.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.05 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,326.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,257.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.10 -1.9%
Abbott India Ltd. Standalone 2022-03 29.95 21,081.50 +0.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,039.45 -1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,343.95 -0.7%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,027.05 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,326.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,257.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,518.10 -1.9%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,081.50 +0.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,039.45 -1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,343.95 -0.7%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,027.05 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,326.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,257.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,518.10 -1.9%
Abbott India Ltd. Standalone 2022-03 798.70 21,081.50 +0.5%

FAQ's On Tejnaksh Healthcare Ltd.

What is Tejnaksh Healthcare share price?

Can I buy Tejnaksh Healthcare shares now?

What is the Market Cap of Tejnaksh Healthcare?

What are the key metrics to analyse Tejnaksh Healthcare?

What is the 52 Week High and Low of Tejnaksh Healthcare?

What is the trend of Tejnaksh Healthcare share price?